Robert W. Shaw
SEC Form 4 insider trading activity
Robert W. Shaw has filed 1 SEC Form 4 filing (1 transaction rows) across 1 company, with disclosures dating back to 2025. 1 of those filings fall inside the rolling window. Most recent filing: Nov 26, 2025.
On the most recent filing, Robert W. Shaw is listed as Director at ULTRALIFE CORP. Inside the rolling window, Robert W. Shaw reported 1 open-market purchase totaling $10K in ULBI and no open-market sales.
Companies traded
Other insiders at ULBI
Insider Buying
$10K
reported purchases (SEC code P)
Insider Selling
$0
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Robert W. Shaw made?
Robert W. Shaw has filed 1 SEC Form 4 filing (1 transaction rows) across 1 company since 2025.
Which companies does Robert W. Shaw trade?
Robert W. Shaw has filed SEC Form 4 disclosures for 1 company, including ULBI.
When was Robert W. Shaw's most recent SEC Form 4 filing?
Robert W. Shaw's most recent SEC Form 4 filing on Tracefour is dated Nov 26, 2025.
What is Robert W. Shaw's total buy and sell value in the current window?
Inside the rolling retention window, Robert W. Shaw bought $10K and sold $0 based on SEC Form 4 filings.
What was Robert W. Shaw's largest disclosed transaction?
The largest disclosed transaction in the current window is a purchase of 1,750 ULBI shares on 2025-11-24, worth $10K, per SEC Form 4 filings.